Hao Zeng Selected Research

Prostatic Neoplasms (Prostate Cancer)

6/2022	The P2 purinoceptors in prostate cancer.
3/2022	Predictors of efficacy of corticosteroid switching from abiraterone plus prednisone to dexamethasone in patients with metastatic castration-resistant prostate cancer.
11/2021	The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.
10/2021	Phase I clinical trial of HC-1119: A deuterated form of enzalutamide.
8/2021	Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone.
1/2021	Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients.
1/2021	Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: Association with patient outcome under abiraterone.
1/2021	Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
1/2021	Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis.
10/2020	The AKR1C3/AR-V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Zeng Research Topics

Disease

59	Neoplasms (Cancer) 09/2022 - 11/2006
49	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 03/2005
30	Infections 01/2022 - 12/2008
17	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2009
14	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2011
12	Spinal Tuberculosis (Pott's Disease) 03/2020 - 10/2013
9	Sepsis (Septicemia) 01/2021 - 10/2015
8	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2013
8	Inflammation (Inflammations) 09/2021 - 08/2009
7	Pancreatitis 01/2022 - 01/2016
7	Staphylococcal Infections 01/2022 - 10/2015
7	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 09/2015
7	Adenocarcinoma 01/2022 - 03/2005
6	Carcinogenesis 05/2020 - 06/2009
6	Tuberculosis (Tuberculoses) 01/2018 - 01/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
4	Congenital Preauricular Fistulae 01/2022 - 10/2015
4	Disease Progression 12/2021 - 09/2015
4	Pneumonia (Pneumonitis) 01/2021 - 02/2016
4	Wounds and Injuries (Trauma) 01/2021 - 07/2010
4	Bacteremia 01/2021 - 12/2015
4	Acute Necrotizing Pancreatitis 04/2020 - 01/2017
4	Carcinoma (Carcinomatosis) 01/2019 - 11/2006
4	Kyphosis 01/2018 - 11/2015
3	COVID-19 01/2021 - 01/2020
3	Hypoxia (Hypoxemia) 04/2013 - 04/2009
2	Hyperthermia 01/2022 - 06/2018
2	Intra-Abdominal Hypertension 01/2022 - 04/2020
2	Adenocarcinoma of Lung 07/2021 - 01/2021
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 01/2021
2	Reperfusion Injury 01/2021 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2013
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
21	VaccinesIBA 01/2022 - 01/2012
12	Biomarkers (Surrogate Marker)IBA 12/2021 - 11/2006
11	AntigensIBA 01/2022 - 03/2005
11	AndrogensIBA 10/2020 - 07/2010
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2013
8	Pharmaceutical PreparationsIBA 09/2022 - 11/2002
8	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
7	abirateroneIBA 03/2022 - 08/2017
6	Transcription Factors (Transcription Factor)IBA 09/2022 - 04/2009
6	MicroRNAs (MicroRNA)IBA 09/2021 - 10/2017
6	Peptides (Polypeptides)IBA 07/2021 - 07/2010
6	Sunitinib (Sutent)FDA Link 01/2021 - 01/2009
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2013
5	Biological ProductsIBA 01/2022 - 11/2006
5	RNA Polymerase II (RNA Polymerase B)IBA 01/2022 - 10/2015
5	EnzymesIBA 01/2022 - 11/2007
5	EpitopesIBA 07/2021 - 01/2019
5	Hormones (Hormone)IBA 01/2020 - 01/2010
5	coactivator-associated arginine methyltransferase 1IBA 11/2017 - 05/2013
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
4	Docetaxel (Taxotere)FDA Link 11/2021 - 08/2017
4	C-Reactive ProteinIBA 10/2020 - 01/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 02/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
3	ChromatinIBA 01/2022 - 04/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Apoptosis Regulatory ProteinsIBA 05/2021 - 04/2009
3	AntibodiesIBA 05/2021 - 11/2013
3	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2016
3	CytokinesIBA 03/2018 - 06/2010
3	Interleukin-17 (Interleukin 17)IBA 03/2018 - 10/2012
3	ElementsIBA 01/2017 - 11/2007
3	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2016 - 01/2014
3	Sorafenib (BAY 43-9006)FDA Link 01/2015 - 07/2010
3	SurvivinIBA 07/2010 - 11/2006
2	TitaniumIBA 06/2022 - 10/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 08/2021
2	Prednisone (Sone)FDA LinkGeneric 03/2022 - 08/2021
2	Bone Cements (Bone Glue)IBA 01/2022 - 06/2018
2	enzalutamideIBA 10/2021 - 01/2020
2	Capsules (Microcapsules)IBA 09/2021 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 09/2021 - 10/2012
2	Abiraterone AcetateIBA 08/2021 - 11/2018
2	Alkaline PhosphataseIBA 08/2021 - 12/2018
2	Therapeutic UsesIBA 08/2021 - 02/2016
2	LigandsIBA 05/2021 - 06/2010
2	Vancomycin FDA LinkGeneric 01/2021 - 02/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 01/2021
2	Immunodominant EpitopesIBA 01/2021 - 07/2015
2	Neutralizing AntibodiesIBA 01/2021 - 09/2009
2	LipidsIBA 12/2020 - 01/2017
2	Interleukin-8 (Interleukin 8)IBA 05/2020 - 08/2009
2	staphylococcal enterotoxin BIBA 01/2020 - 07/2015

Therapy/Procedure

30	Therapeutics 01/2022 - 11/2007
20	Castration 03/2022 - 09/2010
14	Debridement 03/2020 - 10/2013
11	Drug Therapy (Chemotherapy) 03/2021 - 08/2015
9	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 01/2012
7	Immunotherapy 01/2022 - 10/2015
6	Radiotherapy 01/2021 - 03/2006
5	Bone Transplantation (Bone Grafting) 03/2020 - 06/2015
4	Curettage 01/2020 - 01/2019
4	Decompression 04/2016 - 01/2015
3	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 05/2016